Sort
15,842 grants matching “pancreatic cancer”
TARGETING PATHWAY STHAT PROCESS ENDOGENOUS TAXIC METABOLITES IN PANCREATIC CANCERS
$388,633Whitehead Institute For Biomedical Research · · FY2012 · Department of the Army
Optimizing Ultrasound Enhanced Delivery of Therapeutics
$388,631Flemming Forsberg · Thomas Jefferson University · R01 · FY2023 · CA
A systems-metabolism approach to identify mitochondria-dependent vulnerabilities in colorectal cancer
$388,489David Francis Kashatus · University Of Virginia · U54 · FY2025 · CA
Role of type 2 immune response in pancreatic cancer tumorigenesis
$388,432Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Mechanisms of homologous recombination in yeast
$388,368Lorraine S Symington · Columbia University Health Sciences · R01 · FY2017 · GM
Combining Machine Learning and Nanofluidic Technology for The Multiplexed Diagnosis of Pancreatic Adenocarcinoma
$388,274David Aaron Issadore · University Of Pennsylvania · R33 · FY2023 · CA
THE AGING MICROENVIRONMENT AS A DRIVER OF PANCREATIC CANCER METASTASIS
$388,194The Johns Hopkins University · · FY2025 · Defense Health Agency
The histone deacetylase SIRT6 modulates Transcriptional pausing
$388,080Raul Mostoslavsky · Massachusetts General Hospital · R01 · FY2021 · GM
The histone deacetylase SIRT6 modulates Transcriptional pausing
$388,080Raul Mostoslavsky · Massachusetts General Hospital · R01 · FY2022 · GM
The histone deacetylase SIRT6 modulates Transcriptional pausing
$388,080Raul Mostoslavsky · Massachusetts General Hospital · R01 · FY2020 · GM
The histone deacetylase SIRT6 modulates Transcriptional pausing
$388,080Raul Mostoslavsky · Massachusetts General Hospital · R01 · FY2019 · GM
Dectin-1 signaling drives pancreatic oncogenesis by inducing macrophage-mediated adaptive immune suppression
$387,731George Miller · New York University School Of Medicine · R01 · FY2018 · CA
Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis
$387,731Yi-Chieh Nancy Du · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Investigating a novel glutamine metabolism pathway in pancreatic cancer
$387,731Alec Kimmelman · New York University School Of Medicine · R01 · FY2018 · CA
Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis
$387,731Yi-Chieh Nancy Du · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Dectin-1 signaling drives pancreatic oncogenesis by inducing macrophage-mediated adaptive immune suppression
$387,731Kwok Kin Wong · New York University School Of Medicine · R01 · FY2021 · CA
Investigating a novel glutamine metabolism pathway in pancreatic cancer
$387,731Alec Kimmelman · New York University School Of Medicine · R01 · FY2017 · CA
Project 3 : Diagnosis and Management of Pancreatic Cysts
$387,688Anne Marie Lennon · Johns Hopkins University · P50 · FY2021 · CA
Design of MEK Inhibitor Regimens for the Treatment of Pancreatic Cancer
$387,649Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
Preclinical platform for theranostic nanoparticles in pancreatic cancer
$387,617Nancy J Halas · Rice University · U01 · FY2010 · CA
Transcription Factor Mutants of Yeast
$387,570Karen M Arndt · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · GM
Parameters that Underlie Treg Insufficiency in Autoimmune Diabetes
$387,436Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Parameters that Underlie Treg Insufficiency in Autoimmune Diabetes
$387,436Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DK
Mechanisms of homologous recombination in yeast
$387,417Lorraine S Symington · Columbia University Health Sciences · R01 · FY2016 · GM
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology
$387,403Gerard C Blobe · Duke University · R01 · FY2019 · CA